EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Non‐Invasive prenatal testing with rolling circle amplification: Real‐world clinical experience in a non‐molecular laboratory

Matthew L Saidel iD, Uma Ananth, Donna Rose, Cara Farrell

Journal of Clinical Laboratory Analysis · 2023-03 · 37 (6)

DOI: 10.1002/jcla.24870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 27.03.2023. Verfasst von Matthew L Saidel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Women's Health USA and Medical Director, Women's Health Connecticut, Rocky Hill, Connecticut, USA. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐invasive prenatal testing (NIPT) using cell‐free DNA (cfDNA) circulating in maternal blood provides a sensitive and specific screening technique for common fetal aneuploidies, but the high cost and workflow complexity of conventional methodologies limit its widespread implementation. A unique rolling circle amplification methodology reduces cost and complexity, providing a promising alternative for increased global accessibility as a first‐tier test.

Methods

In this clinical study, 8160 pregnant women were screened on the Vanadis system for trisomies 13, 18, and 21, and positive results were compared to clinical outcomes where available.

Results

The Vanadis system yielded a 0.07% no‐call rate, a 98% overall sensitivity, and a specificity of over 99% based on available outcomes.

Conclusion

The Vanadis system provided a sensitive, specific, and cost‐effective cfDNA assay for trisomies 13, 18, and 21, with good performance characteristics and low no‐call rate, and it eliminated the need for either next‐generation sequencing or polymerase chain reaction amplification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal DiagnosisCell-Free Nucleic AcidsPregnancyHumansFemaleTrisomyAneuploidyTrisomy 13 Syndrome

Stichwörter der Autor:innen

NIPSNIPTaneuploidiescell-free fetal DNAcfDNAnext-generation sequencingnon-invasive prenatal testingprenatal screeningrolling circle amplificationtrisomies

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Women's Health USA and Medical Director, Women's Health Connecticut, Rocky Hill, Connecticut, USA.
  • Umagen LLC, Shrewsbury, Massachusetts, USA.
  • Women's Health Connecticut Laboratory, Rocky Hill, Connecticut, USA.
  • Ancillary Growth Women's Health Connecticut, Rocky Hill, Connecticut, USA.

ORCID-Profile: Matthew L Saidel

Zitieren

APA

Saidel, M. L., Ananth, U., Rose, D., & Farrell, C. (2023). Non‐Invasive prenatal testing with rolling circle amplification: Real‐world clinical experience in a non‐molecular laboratory. Journal of Clinical Laboratory Analysis, 37(6). https://doi.org/10.1002/jcla.24870

Vancouver

Saidel ML, Ananth U, Rose D, Farrell C. Non‐Invasive prenatal testing with rolling circle amplification: Real‐world clinical experience in a non‐molecular laboratory. Journal of Clinical Laboratory Analysis. 2023;37(6). doi:10.1002/jcla.24870

BibTeX
@article{Saidel2023,
  author = {Saidel, Matthew L and Ananth, Uma and Rose, Donna and Farrell, Cara},
  title = {Non‐Invasive prenatal testing with rolling circle amplification: Real‐world clinical experience in a non‐molecular laboratory},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2023},
  volume = {37},
  number = {6},
  doi = {10.1002/jcla.24870}
}
Kostenlos starten →